Paper Details

  1. Home
  2. Paper Details

Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.

Author: StaskinDavid R, TeAlexis E

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study investigated the improvement in urinary symptoms in women with mixed urinary incontinence (MUI), a common condition affecting about one-third of incontinent women, who received solifenacin succinate for overactive bladder (OAB) for up to 52 weeks. This medication is effective for urge incontinence, so the study aimed to evaluate its effectiveness for MUI, a more complex type of incontinence.
Paper Details　
Original Abstract of the Article :
To evaluate urinary symptom relief in women with mixed urinary incontinence (MUI) treated for up to 52 weeks with solifenacin succinate for overactive bladder (OAB), as MUI is a complex and distressing condition reported by about a third of incontinent women, and with confirmed efficacy in OAB-relat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1464-410X.2006.06150.x

データ提供：米国国立医学図書館（NLM）

Mixed Urinary Incontinence: A Desert of Unpredictable Leaks

Imagine a traveler in a desert oasis, facing a constant threat of unpredictable sandstorms. This is the reality for many women with mixed urinary incontinence (MUI), a condition characterized by both urge and stress incontinence. This study investigates the effectiveness of solifenacin succinate in treating MUI, offering a potential solution for managing unpredictable leaks.

Solifenacin Succinate: A Potential Oasis for MUI

This study found that solifenacin succinate was effective in providing symptom relief in women with MUI. This is a significant finding, offering hope for women struggling with this distressing condition. The study found that solifenacin succinate was particularly effective in reducing urge incontinence episodes, suggesting a potential for improved bladder control and quality of life.

Navigating the Desert of Urinary Incontinence

This study highlights the potential of solifenacin succinate in treating MUI, a condition that can significantly impact quality of life. It emphasizes the importance of finding effective treatments for women experiencing this common and often embarrassing problem. As researchers, we continue to explore the vast desert of urinary incontinence, seeking to discover new treatments and improve the lives of those affected by this challenging condition.

Dr.Camel's Conclusion

This study demonstrates the potential of solifenacin succinate in providing symptom relief for women with mixed urinary incontinence. While further research is needed to fully understand its long-term effects, this study offers a beacon of hope for women struggling with this debilitating condition. We, as researchers, continue our journey through the desert of urinary incontinence, seeking to discover new treatments and improve the lives of those affected by this challenging condition.

Date :
  1. Date Completed 2006-06-28
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

16686722

DOI: Digital Object Identifier

10.1111/j.1464-410X.2006.06150.x

Related Literature

Article Analysis
・Effective treatment of urinary incontinence
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.